We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Enzon Pharmaceuticals Inc.s financial performance into perspective.
| Upcoming Events | |
|---|---|
| Details on upcoming events are not yet available. Please click here to be notified of all upcoming events. | |
| Archived Events | |||||
|---|---|---|---|---|---|
|
Aug 3, 2010 5:00 PM ET |
Enzon Second Quarter Earnings Call
|
||||
|
May 10, 2010 5:00 PM ET |
First Quarter Earnings Call
|
||||
|
Feb 17, 2010 10:00 AM ET |
Fourth Quarter Earnings Call
|
||||
|
Nov 3, 2009 10:00 AM ET |
Third Quarter Earnings Call
|
||||
|
Aug 5, 2009 9:30 AM ET |
2009 BMO Capital Markets 9th Annual Focus on Healthcare Conference
Speaker: Jeffrey H. Buchalter, President & CEO
|
||||
|
Aug 4, 2009 9:00 AM ET |
Second Quarter Earnings Call
|
||||
|
Jun 23, 2009 2:00 PM ET |
PEG SN38 Phase II Initiation
|
||||
|
Feb 19, 2009 10:00 AM ET |
Fourth Quarter Earnings Call
|
||||
|
Aug 6, 2008 9:00 AM |
Second Quarter Earnings Call
|
||||
|
May 7, 2008 10:00 AM |
First Quarter Earnings Call
|
||||
|
Oct 30, 2007 8:30 AM ET |
Enzon Investor Day
|
||||
|
Aug 2, 2007 10:00 AM |
Second Quarter Earnings Call
|
||||
|
Mar 12, 2007 1:40 PM |
Cowen and Company 27th Annual Healthcare Conference
|
||||
|
Feb 13, 2007 10:00 AM |
Fourth Quarter Earnings Call
|
||||
| (ENZN) NASDAQ | |
| Last Trade | 10.580 |
| Change(%) |
0.17
|
| Volume | 208,700 |
| Sep 2, 2010 4:00 PM ET | |
Sign up to receive Enzon Pharmaceuticals Inc. financial information by email.
News
Details on upcoming events are not yet available.
click here to be notified of all upcoming events.


Really Simple Syndication is a format designed for sharing web content such as headlines. An RSS feed highlights fresh material for you, so you don't have to repeatedly check a site yourself for updates.
Company continues to progress as an innovative oncology
development company
--Company is transformed to be exclusively focused on its pipeline--
